BioScience Health Innovations, Inc.
BHIC OTC
SEC CIK 1784440
Follow BioScience Health Innovations
Weekly email: filings, results, news
Revenue, last quarter
$1M
−41% vs same quarter last year
Net income
−$185.8K
−140.6% vs same quarter last year
EPS, diluted
−$0.02
−150% vs same quarter last year
Operating cash flow
−$541.9K
−290.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $5.7M | $642.1K |
| FY24 | $1.8M | $87K |
| FY23 | $597.6K | −$251.5K |
| FY22 | $69.3K | −$170.5K |
| FY21 | $0 | −$25.6K |
| FY20 | $0 | −$7.7K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 57% | 12.6% | 11.3% |
| FY24 | 70.9% | 4.7% | 4.7% |
| FY23 | 81.1% | −42.1% | −42.1% |
| FY22 | 86% | −245.8% | −245.8% |
| FY21 | - | - | - |
| FY20 | - | - | - |
- BioScience Health Innovations
- Technology median
Show the numbers
| Year | BioScience Health Innovations | Technology median |
|---|---|---|
| FY25 | 11.3% | −2.2% |
| FY24 | 4.7% | −6.1% |
| FY23 | −42.1% | −10.6% |
| FY22 | −245.8% | −13.6% |
| FY21 | - | −7.7% |
| FY20 | - | −9.7% |
News
No stories filed under BioScience Health Innovations yet - coverage appears here as the news feed clusters it.